annual D&A:
$6.08M-$419.00K(-6.45%)Summary
- As of today (September 14, 2025), BBIO annual depreciation & amortization is $6.08 million, with the most recent change of -$419.00 thousand (-6.45%) on December 31, 2024.
- During the last 3 years, BBIO annual D&A has risen by +$232.00 thousand (+3.97%).
- BBIO annual D&A is now -10.28% below its all-time high of $6.77 million, reached on December 31, 2022.
Performance
BBIO Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$1.32M+$33.00K(+2.57%)Summary
- As of today (September 14, 2025), BBIO quarterly depreciation & amortization is $1.32 million, with the most recent change of +$33.00 thousand (+2.57%) on June 30, 2025.
- Over the past year, BBIO quarterly D&A has dropped by -$257.00 thousand (-16.33%).
- BBIO quarterly D&A is now -50.99% below its all-time high of $2.69 million, reached on June 30, 2021.
Performance
BBIO quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$5.51M-$257.00K(-4.46%)Summary
- As of today (September 14, 2025), BBIO TTM depreciation & amortization is $5.51 million, with the most recent change of -$257.00 thousand (-4.46%) on June 30, 2025.
- Over the past year, BBIO TTM D&A has dropped by -$888.00 thousand (-13.89%).
- BBIO TTM D&A is now -18.68% below its all-time high of $6.77 million, reached on December 31, 2022.
Performance
BBIO TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
BBIO Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -6.5% | -16.3% | -13.9% |
| 3 y3 years | +4.0% | -16.8% | +4.7% |
| 5 y5 years | - | - | - |
BBIO Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -10.3% | +4.0% | -20.7% | +2.6% | -18.7% | +4.7% |
| 5 y | 5-year | -10.3% | +96.7% | -51.0% | +397.0% | -18.7% | +303.4% |
| alltime | all time | -10.3% | +2379.6% | -51.0% | +4965.4% | -18.7% | >+9999.0% |
BBIO Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $1.32M(+2.6%) | $5.51M(-4.5%) |
| Mar 2025 | - | $1.28M(-6.1%) | $5.76M(-5.1%) |
| Dec 2024 | $6.08M(-6.5%) | $1.37M(-11.1%) | $6.08M(-3.5%) |
| Sep 2024 | - | $1.54M(-2.3%) | $6.29M(-1.6%) |
| Jun 2024 | - | $1.57M(-1.4%) | $6.39M(-1.0%) |
| Mar 2024 | - | $1.60M(+0.7%) | $6.46M(-0.6%) |
| Dec 2023 | $6.49M(-4.1%) | $1.58M(-3.3%) | $6.49M(-1.1%) |
| Sep 2023 | - | $1.64M(+0.1%) | $6.57M(-0.1%) |
| Jun 2023 | - | $1.64M(+0.2%) | $6.58M(+0.8%) |
| Mar 2023 | - | $1.63M(-1.6%) | $6.52M(-3.7%) |
| Dec 2022 | $6.77M | $1.66M(+0.9%) | $6.77M(+2.0%) |
| Sep 2022 | - | $1.65M(+4.0%) | $6.64M(+26.3%) |
| Jun 2022 | - | $1.58M(-16.0%) | $5.26M(-17.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $1.88M(+23.5%) | $6.36M(+8.9%) |
| Dec 2021 | $5.84M(+89.2%) | $1.53M(+475.8%) | $5.84M(+35.3%) |
| Sep 2021 | - | $265.00K(-90.1%) | $4.32M(+6.5%) |
| Jun 2021 | - | $2.69M(+96.8%) | $4.05M(+196.8%) |
| Mar 2021 | - | $1.36M(+265.0%) | $1.36M(+120.9%) |
| Dec 2020 | $3.09M(+1160.4%) | - | - |
| Sep 2019 | - | $374.00K(+183.3%) | $618.00K(+92.5%) |
| Jun 2019 | - | $132.00K(+17.9%) | $321.00K(+39.0%) |
| Mar 2019 | - | $112.00K(+45.5%) | $231.00K(+59.3%) |
| Dec 2018 | $245.00K(-5.8%) | - | - |
| Sep 2018 | - | $77.00K(+83.3%) | $145.00K(+113.2%) |
| Jun 2018 | - | $42.00K(+61.5%) | $68.00K(+161.5%) |
| Mar 2018 | - | $26.00K | $26.00K |
| Dec 2017 | $260.00K | - | - |
FAQ
- What is BridgeBio Pharma, Inc. annual depreciation & amortization?
- What is the all time high annual D&A for BridgeBio Pharma, Inc.?
- What is BridgeBio Pharma, Inc. annual D&A year-on-year change?
- What is BridgeBio Pharma, Inc. quarterly depreciation & amortization?
- What is the all time high quarterly D&A for BridgeBio Pharma, Inc.?
- What is BridgeBio Pharma, Inc. quarterly D&A year-on-year change?
- What is BridgeBio Pharma, Inc. TTM depreciation & amortization?
- What is the all time high TTM D&A for BridgeBio Pharma, Inc.?
- What is BridgeBio Pharma, Inc. TTM D&A year-on-year change?
What is BridgeBio Pharma, Inc. annual depreciation & amortization?
The current annual D&A of BBIO is $6.08M
What is the all time high annual D&A for BridgeBio Pharma, Inc.?
BridgeBio Pharma, Inc. all-time high annual depreciation & amortization is $6.77M
What is BridgeBio Pharma, Inc. annual D&A year-on-year change?
Over the past year, BBIO annual depreciation & amortization has changed by -$419.00K (-6.45%)
What is BridgeBio Pharma, Inc. quarterly depreciation & amortization?
The current quarterly D&A of BBIO is $1.32M
What is the all time high quarterly D&A for BridgeBio Pharma, Inc.?
BridgeBio Pharma, Inc. all-time high quarterly depreciation & amortization is $2.69M
What is BridgeBio Pharma, Inc. quarterly D&A year-on-year change?
Over the past year, BBIO quarterly depreciation & amortization has changed by -$257.00K (-16.33%)
What is BridgeBio Pharma, Inc. TTM depreciation & amortization?
The current TTM D&A of BBIO is $5.51M
What is the all time high TTM D&A for BridgeBio Pharma, Inc.?
BridgeBio Pharma, Inc. all-time high TTM depreciation & amortization is $6.77M
What is BridgeBio Pharma, Inc. TTM D&A year-on-year change?
Over the past year, BBIO TTM depreciation & amortization has changed by -$888.00K (-13.89%)